Naseem Zojwalla - Jan 31, 2022 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
3
Date filed
2/3/2022, 05:58 PM
Next filing
Feb 3, 2022

No securities are beneficially owned.